Opinion - The ugly truth about the student loan caps in Trump's ‘big beautiful' law
The bill, now signed into law, will cap graduate unsubsidized student loans at $20,500, with a $100,000 total cap on top of undergrad loans, and phase out Grad PLUS loans. These changes are especially detrimental for those pursuing clinician roles, such as nurse practitioners. Nurse practitioners play a crucial role, filling gaps in primary care — especially in rural and underserved communities. Their presence expands access, relieves pressure on healthcare systems and allows physicians to focus on the most complex cases.
Graduate education is not optional for becoming a nurse practitioner. Nor is it optional for becoming faculty to teach the next generation of physicians and nurses. Weakening the pipeline of advanced practice nurses doesn't just hurt nursing, it threatens the entire care delivery system.
For nursing, this is a moment where education is already strained. Nurses have left the profession en masse since the COVID-19 pandemic and older nurses are retiring. We urgently need more nurses and nurse educators in the pipeline. Yet in 2023, enrollment in bachelor's-level nursing programs grew by just 0.3 percent. Meanwhile, enrollment in master's and Ph.D. nursing programs declined by 0.9 percent and 3.1 percent, respectively. That same year, U.S. nursing schools turned away more than 65,000 qualified applications due to a lack of faculty, clinical placements and funding — not because of a lack of interest.
Faculty shortages are especially dire. Nearly 2,000 full-time faculty vacancies remain unfilled nationwide, according to the American Association of Colleges of Nursing. These positions require a master's or doctoral degree — precisely the kind of education now placed at risk by this legislation. Without nurse educators, we cannot train the next generation of nurses at any level.
This law also directly contradicts the Make America Healthy Again initiative, which calls on healthcare systems to take on chronic disease through prevention. Nurses make up the largest segment of the healthcare workforce. Their education emphasizes prevention and whole-person care for people and communities. Nurses are central to the shift from reactive 'sick care' to proactive prevention, so restricting their ability to enter the profession is not just shortsighted, it's self-defeating.
A diminished nursing workforce will trigger a familiar cycle: reduced access, longer wait times, more chronic disease and an even more overwhelmed workforce. And these consequences won't be limited to nurses — they will affect physicians, hospitals, insurers and, most of all, everyday Americans.
This is a national health issue. While the bill has passed, it is not too late to mitigate its harm. Policymakers must find alternative solutions, from scholarship expansion to loan forgiveness, to ensure access to graduate nursing education remains within reach. We cannot solve a workforce shortage and a chronic disease crisis by cutting off the professionals trained to fix it.
Sarah Szanton is dean of the Johns Hopkins School of Nursing.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
AICPA backs SAFE Act to aid tax filing for domestic abuse survivors
The American Institute of CPAs (AICPA) has announced its support for the bill introduced by Senator John Fetterman that aims to provide a critical tax filing option for individuals who have experienced spousal abuse or abandonment. The Survivor Assistance for Fear-free and Easy Tax Filing Act of 2025 (SAFE Act), identified as S. 2129, proposes that survivors of domestic violence or spousal abandonment be allowed to file their taxes as if they were single. Currently, the tax code mandates that married individuals file under one of two categories: married filing jointly or married filing separately. These requirements can compel survivors to engage with an abusive or absent spouse, complicating the filing process. The SAFE Act intends to empower survivors by enabling them to file their tax returns independently, thereby granting them access to tax benefits such as credits and deductions without being financially linked to their abusive or absent partners. This legislation seeks to enhance the autonomy of survivors in managing their tax obligations, thereby reducing the influence that abusive or absent spouses may have over their financial matters. AICPA Tax Policy & Advocacy senior manager Daniel Hauffe said: 'Many tax practitioners have one or more clients to which this legislation is applicable in some form and they are restrained due to current law in how to best help these clients. 'This legislation addresses a critical gap in the US tax system that affects survivors of domestic abuse or spousal abandonment. 'This is a practical step toward tax equity and survivor protection, ensuring that the tax system does not unintentionally perpetuate harm or dependency in abusive situations. We are grateful to Senator Fetterman for his leadership on this issue and ask that other members of Congress join us in supporting this bill.' "AICPA backs SAFE Act to aid tax filing for domestic abuse survivors" was originally created and published by The Accountant, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Yahoo
22 minutes ago
- Yahoo
Democrats use obscure law to seek release of Epstein files
Democrats moved Wednesday to force Donald Trump to release files from the investigation into notorious sex offender Jeffrey Epstein, invoking an obscure law to keep up the pressure on an issue that has roiled the US president's administration. The White House has been facing increasingly intense demands to be more transparent about the disgraced financier, who died in federal prison in 2019 while awaiting trial on sex-trafficking charges. The president raised further questions about his past relationship with Epstein on Tuesday when he told reporters he fell out with his former friend after the disgraced financier "stole" employees from the spa at his Mar-a-Lago resort. The Justice Department angered Trump supporters earlier this month when it said Epstein had died by suicide and had no "client list" -- rebuffing conspiracy theories about the supposed complicity of high-profile Democrats that leading figures in Trump's MAGA movement had been pushing for years. Senate Minority Leader Chuck Schumer and the Democrats on the Homeland Security and Governmental Affairs Committee wrote to the Justice Department asking for the materials under a section of federal law known as the "rule of five." The measure -- introduced a century ago but rarely used -- requires government departments to provide relevant information if any five members of the Senate's chief watchdog panel request it. It is not clear if it could be enforced in court but even if the effort fails it keeps the spotlight on an issue that has upended Trump's summer, dividing Republicans and leading to the early closure of the House of Representatives. Trump has urged his supporters to drop demands for the Epstein files, but Democrats in Congress -- with limited Republican support -- have been seeking a floor vote to force their release. House Oversight Committee Democrats, backed by some Republicans, approved a subpoena last week for the Justice Department to hand over the documents, although the demand has yet to be sent. Lawmakers have also been seeking testimony from Epstein's accomplice Ghislaine Maxwell, who is serving 20 years in prison for her role in his crimes. Maxwell's lawyer has said she would speak to the House Oversight and Government Reform Committee if granted immunity for her testimony. "The Oversight Committee will respond to Ms. Maxwell's attorney soon, but it will not consider granting congressional immunity for her testimony," a spokesman for the panel said. Democrats have also sought to attach votes on the Epstein files to unrelated bills multiple times, prompting Speaker Mike Johnson to send lawmakers home for the summer a day early last week rather than risk them succeeding. "Donald Trump promised he would release the Epstein files while he was on the campaign trail. He made that promise, and he has yet to do it," Schumer said in a speech Tuesday on the Senate floor. ft/dw
Yahoo
22 minutes ago
- Yahoo
US health officials crack down on kratom-related products after complaints from supplement industry
WASHINGTON (AP) — U.S. health officials are warning Americans about the risks of an opioid-related ingredient increasingly added to energy drinks, gummies and supplements sold at gas stations and convenience stores, recommending a nationwide ban. The chemical, known as 7- hydroxymitragynine, is a component of kratom, a plant native to Southeast Asia that has gained popularity in the U.S. as an unapproved treatment for pain, anxiety and drug dependence. In recent months, dietary supplement companies that sell kratom have been urging the Food and Drug Administration to crack down on the products containing 7-OH, portraying it as a dangerously concentrated, synthetic form of the original ingredient. The FDA action 'is not focused on natural kratom leaf products," according to a statement Tuesday by the U.S. Department of Health and Human Services. The agency said it was releasing a report to educate about the risks of '7-OH and its distinction from the kratom plant leaf.' Regulators are also recommending that the ingredient be placed on the federal government's most restrictive list of illegal drugs, which includes LSD and heroin. '7-OH is an opioid that can be more potent than morphine," said FDA Commissioner Marty Makary. "We need regulation and public education to prevent another wave of the opioid epidemic.' The agency's recommendation will be reviewed by the Drug Enforcement Administration, which sets federal rules for high-risk drugs including prescription medicines and illicit substances. A national ban wouldn't take effect until the agency drafts and finalizes new rules governing the ingredient. Federal regulators have been scrutinizing kratom for about a decade after reports of addiction, injury and overdose. But users and distributors have long opposed efforts to regulate it, saying kratom could be a safer alternative to opioid painkillers that sparked the ongoing drug addiction epidemic. Last month, the FDA issued warning letters to seven companies selling drinks, gummies and powders infused with 7-OH. Regulators said the products violated FDA rules because they have not been evaluated for safety and, in some cases, claimed to treat medical conditions, including pain, arthritis and anxiety. Supplement executives quickly applauded the move. The FDA "demonstrated the exact kind of data-driven, proactive regulatory excellence needed to safeguard unwitting consumers across the U.S.,' said Ryan Niddel of Diversified Botanics, a Utah-based company that sells kratom supplements. An industry group, the American Kratom Association, has lobbied Congress for years against restrictions on the plant. Legislation supported by the group would prohibit the FDA from regulating kratom more strictly than food and dietary supplements. In recent years, the association has lobbied at the state level for bills that limit synthetic 7-OH products. On Tuesday, a rival group that supports the availability of 7-OH drugs criticized the government's move, pointing to the influence of kratom suppliers. 'Big kratom trade groups have spent years blaming 7-OH for harms caused by their own unregulated products, because it threatens their market share,' the Holistic Alternative Recovery Trust stated in an emailed message. Nearly a decade ago, the federal government came close to banning kratom. In 2016, the DEA announced plans to add it to the government's most restrictive schedule 1, reserved for drugs that have no medical use and a high potential for abuse. But the plan stalled after a flood of public complaints, including a letter signed by more than 60 members of Congress. The FDA then began studying the ingredient, concluding in 2018 that kratom contains many of the same chemicals as opioids, the addictive class of drugs that includes painkillers like OxyContin as well as heroin and fentanyl. Since then, FDA regulators have continued to issue warnings about cases of injury, addiction and death with kratom supplements, which are usually sold in capsules or powders. In recent months, the FDA has also issued warnings on other unapproved drugs sold as supplements or energy drinks, including the antidepressant tianeptine. Sometimes referred to collectively as 'gas station heroin,' the drugs have been restricted by several states, but they are not scheduled at the federal level. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content. Matthew Perrone, The Associated Press
